Ribavirin
Showing 1 - 25 of 1,209
HEAD & NECK Cancer Trial in New York (ribavirin)
Active, not recruiting
- HEAD & NECK Cancer
- ribavirin
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jan 11, 2023
Human Papillomavirus (HPV)-Related Malignancies, Recurrent/Metastatic (R/M) Human Papillomavirus (HPV)-Related Malignancies
Completed
- Human Papillomavirus (HPV)-Related Malignancies
- Recurrent/Metastatic (R/M) Human Papillomavirus (HPV)-Related Malignancies
- Ribavirin
-
Basking Ridge, New Jersey
- +5 more
Dec 14, 2022
Viral Hemorrhagic Fever Trial in Landstuhl (Ribavirin)
Recruiting
- Viral Hemorrhagic Fever
- Ribavirin
-
Landstuhl, APO Ae, GermanyLandstuhl Regional Medical Center
Apr 3, 2022
SARS-CoV Infection, Covid19 Trial in New Brunswick (Nitazoxanide, Placebo Nitazoxanide, Ribavirin)
Terminated
- SARS-CoV Infection
- Covid19
- Nitazoxanide
- +5 more
-
New Brunswick, New JerseyRobert Wood Johnson Medical School
May 3, 2022
Acute Myelogenous Leukemia Trial in Rochester (Decitabine)
Completed
- Acute Myelogenous Leukemia
-
Rochester, New YorkUniversity of Rochester
Jul 1, 2022
Hepatitis C, Cirrhosis Trial (Sofosbuvir/Velpatasvir + Ribavirin, Sofosbuvir/Velpatasvir/Voxilaprevir)
Not yet recruiting
- Hepatitis C
- Cirrhosis
- Sofosbuvir/Velpatasvir + Ribavirin
- Sofosbuvir/Velpatasvir/Voxilaprevir
- (no location specified)
Jul 20, 2022
Covid19, SARS-CoV Infection Trial in Johannesburg (Placebo, DuACT)
Completed
- Covid19
- SARS-CoV Infection
- Placebo
- DuACT
-
Johannesburg, Gauteng, South AfricaSunnyside Office Park
Jul 13, 2022
Hepatitis C, Chronic Trial in Taiwan (P1101 + Ribavirin)
Recruiting
- Hepatitis C, Chronic
- P1101 + Ribavirin
-
Chiayi City, Taiwan
- +7 more
Jun 30, 2022
HIV Trial in New Orleans (Ribavirin)
Completed
- HIV Infections
- Ribavirin
-
New Orleans, Louisiana
- +1 more
Oct 27, 2021
Hepatitis C Virus Trial in Aurora (ribavirin)
Completed
- Hepatitis C Virus
- ribavirin
-
Aurora, ColoradoUniversity of Colorado Denver
Aug 20, 2021
Follicular Lymphoma, Mantle Cell Lymphoma Trial in New York (Ribavirin)
Terminated
- Follicular Lymphoma
- Mantle Cell Lymphoma
- Ribavirin
-
New York, New YorkWeill Cornell Medicine
Sep 20, 2021
Cardiovascular Function and Ribavirin PK/PD in Lassa Fever in
Completed
- Lassa Fever
-
Owo, Ondo State, NigeriaOwo Federal Medical Centre
Oct 12, 2021
Hepatitis C Trial in Denver (Simeprivir (SMV), Sofosbuvir (SOF), Ribavirin (RBV))
Terminated
- Hepatitis C
- Simeprivir (SMV)
- +2 more
-
Denver, ColoradoUniversity of Colorado Denver (Leprino Building)
Aug 16, 2021
HIV Trial in United States (Ribavirin)
Completed
- HIV Infections
- Ribavirin
-
San Diego, California
- +4 more
Oct 28, 2021
Male Infertility, HCV Trial in Al Qalyubiyah, Banha (Sofosbuvir +daclatasvir+ simeprevir+Ribavirin)
Recruiting
- Male Infertility
- HCV
- Sofosbuvir +daclatasvir+ simeprevir+Ribavirin
-
Al Qalyūbīyah, Benha, Egypt
- +1 more
Nov 7, 2022
HIV, Hepatitis B, Hepatitis C Trial (Adefovir dipivoxil, Peginterferon-alfa-2A, Ribavirin)
Withdrawn
- HIV Infections
- +2 more
- Adefovir dipivoxil
- +3 more
- (no location specified)
Oct 28, 2021
Zepatier in Patients With Substance Use
Active, not recruiting
- Hepatitis C
- +3 more
- Elbasvir/Grazoprevir 50 MG-100 MG Oral Tablet [ZEPATIER]
-
Chicago, IllinoisUniversity of Illinois at Chicago
Jun 28, 2022
Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin, Placebo for ABT-450/r/ABT-267)
Completed
- Chronic Hepatitis C Infection
- ABT-450/r/ABT-267, ABT-333
- +4 more
- (no location specified)
Jul 29, 2021
COVID-19 Pneumonia Trial in Mansoura (Ivermectin,ribavirin ,nitazoxanide and zinc)
Recruiting
- COVID-19 Pneumonia
- Ivermectin,ribavirin ,nitazoxanide and zinc
-
Mansoura, Select A State Or Province, EgyptMansoura University Hospital
Jul 9, 2021
Liver Cancer Trial in Houston (Bevacizumab, Atezolizumab, Sofosbuvir)
Not yet recruiting
- Liver Cancer
- Bevacizumab
- +5 more
-
Houston, TexasM D Anderson Cancer Center
Feb 9, 2023
Hepatitis C, Chronic Trial in United States (ISIS 14803, peginterferon alfa, ribavirin)
Completed
- Hepatitis C, Chronic
- ISIS 14803, peginterferon alfa, ribavirin
-
Birmingham, Alabama
- +24 more
Dec 1, 2022